Intriguingly, we discovered that a certain level of astrocytic NF-κB activity is required to maintain some of the neuroprotective features of these cells in AD since its inhibition was associated with reduced expression of the disease-modifying mediator AQP4 as well as higher accumulation of Aβ and tau in mice. The gene discussed is MAPT; the disease is Alzheimer disease.